New host defense mechanisms against Candida species clarify the basis of clinical phenotypes

Journal of Allergy and Clinical Immunology

Volumn 127, Issue 6, 2011, Pages 1433-1437

  Hanna, Suheir ^a   Etzoni, Amos ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Chronic mucocutaneous candidiasis; IL 17; IL 22

Indexed keywords

AUTOIMMUNE REGULATOR PROTEIN; CARD9 PROTEIN; CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR6; DECTIN 1; DECTIN 2; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12 RECEPTOR BETA1; INTERLEUKIN 12P40; INTERLEUKIN 17; INTERLEUKIN 17F; INTERLEUKIN 1BETA; INTERLEUKIN 21; INTERLEUKIN 22; INTERLEUKIN 23; INTERLEUKIN 26; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; PROTEIN; PROTEIN KINASE SYK; RETINOID RELATED ORPHAN RECEPTOR GAMMA; RITUXIMAB; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TRANSFORMING GROWTH FACTOR BETA; UNCLASSIFIED DRUG;

AUTOIMMUNE POLYENDOCRINOPATHY; AUTOIMMUNE POLYENDOCRINOPATHY CANDIDIASIS ECTODERMAL DYSTROPHY; CANDIDA; CANDIDA ALBICANS; CANDIDIASIS; CELL PROLIFERATION; CONTROLLED STUDY; DEFENSE MECHANISM; HOST RESISTANCE; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNITY; INNATE IMMUNITY; INTERLEUKIN 12 RECEPTOR BETA1 DEFICIENCY; INTERLEUKIN 12P40 DEFICIENCY; INTRACELLULAR SIGNALING; MACROPHAGE; MUCOCUTANEOUS CANDIDIASIS; MYCOSIS; NONHUMAN; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEFICIENCY; PROTEIN EXPRESSION; REGULATORY T LYMPHOCYTE; REVIEW; TH17 CELL;

EID: 79957868053     PISSN: 00916749     EISSN: 10976825     Source Type: Journal    
DOI: 10.1016/j.jaci.2011.03.026     Document Type: Article

References (25)

1. Glocker E, Grimbacher B. Chronic mucocutaneous candidiasis and congenital susceptibility to Candida. Curr Opin Allergy Clin Immunol 2010;10:542-50.
2. Conti HR, Gaffen SL. Host responses to Candida albicans: Th17 cells and mucosal candidiasis. Microbes Infect 2010;12:518-27.
3. Puel A, Picard C, Cypowyj S, Lilic D, Abel L, Casanova JL. Inborn errors of mocucotaneous immunity to Candida albicans in humans: a role for IL-17 cytokines? Curr Opin Immunol 2010;22:467-74.
4. Thorpe ES, Handley HE. Chronic tetany and chronic mycelial stomatitis in a child aged four and one half years. Am J Dis Child 1929;38:228-38.
5. Farah CS, Hu Y, Riminton S, Ashman RB. Distinct roles for IL-12p40 and TNF in resistance to oral candidiasis defined by gene-targeting. Oral Microbiol Immunol 2006;21:252-5. (Pubitemid 44336956)
6. Gil ML, Gozalbo D. Role of Toll-like receptors in systemic Candida albicans infections. Front Biosci 2009;14:570-82.
7. Tessarolli V, Gasparoto TH, Lima HR, Figueira EA, Garlet TP, Torres SA, et al. Absence of TLR2 influences survival of neutrophils after infection with Candida albicans. Med Mycol 2010;48:129-40.
8. Drummond RA, Saijo S, Iwakura Y, Brown GD. The role of Syk/Card9 coupled Ctype lectins in antifungal immunity. Eur J Immunol 2011;41:276-81.
9. Netea MG, Marodi L. Innate immune mechanisms for recognition and uptake of Candida species. Trends Immunol 2010;31:346-53.
10. Saijo S, Ikeda S, Yamabe K, Kakuta S, Ushigame H, Akitsu A, et al. Dectin-2 recognition of alfa mannans and induction of Th17 cell differentiation is essential for host defence against Candida albicans. Immunity 2010;32:681-91.
11. Palm NW, Medzhitov R. Antifungal defence turns 17. Nat Immunol 2007;8:549-51.
12. Kroetz DN, Deepe GS. CCR5 dictates the equilibrium of proinflammatory IL-171 and regulatory Foxp3+ T cells in fungal infection. J Immunol 2010;184:5224-31.
13. Bettelli E, Carrier Y, Gao W, Korn T, Strom B, Oukka M, et al. Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 2006;441:235-8.
14. Gaffen SL. Structure and signalling in the IL-17 receptor family. Nat Rev Immunol 2009;9:556-67.
15. Minegishi Y, Siato M, Tsuchiya S, Tsuge I, Takada H, Hara T, et al. Dominant negative mutations in the DNA binding domain of STAT3 cause hyper IgE syndrome. Nature 2007;448:1058-62. (Pubitemid 47345590)
16. Milner J, Brenchley JM, Laurence A, Freeman AF, Hill BJ, Elias KM, et al. Impaired Th17 cell differentiation in subjects with autosomal dominant hyper IgE syndrome. Nature 2008;452:773-6.
17. Conti HR, Baker O, Freeman AF, Jang WS, Holland SM, Edgerton M, et al. New mechanism of oral immunity to mucosal candidiasis in hyper IgE syndrome. Mucosal Immunol 2011[Epub ahead of print].
18. Puel A, Doffinger R, Natividad A, Chrabieh M, Barcenas-Morales G, Picard C, et al. Autoantibodies against IL17A, IL-17F, and IL-22 in patients with chronic mucocutaneous candidiasis and autoimmune polyendocrine syndrome type I. J Exp Med 2010;207:291-7.
19. Kisard K, Boe Wolff AS, Podkrajsek KT, Tserel L, Link M, Kisard KV, et al. Chronic mucocutaneous candidiasis in APECED or thymoma patients correlates with autoimmunity to Th17 associated cytokines. J Exp Med 2010;207:299-308.
20. Ng WF, von Delwig A, Carmichael AJ, Arkwright PD, Abinun M, Cant AJ, et al. Impaired Th17 responses in patients with chronic mucocutaneous candidiasis with and without autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy. J Allergy Clin Immunol 2010;126:1006-15.
21. Beaucoudrey LD, Samarina A, Bustamante J, Cabot A, Boisson-Dupuis S, Feinberg J, et al. Revisiting human IL-12Rbeta1 deficiency. Medicine 2010;89:381-402.
22. Glocker EO, Hennigs A, Nabavi M, Schaffer AA, Woellner C, Salzer U, et al. A homozygous CARD9 mutation in a family with susceptibility to fungal infections. N Engl J Med 2009;361:1727-35.
23. Ferwerda B, Ferwerda G, Plantinga TS, Willment JA, van Spriel AB, Venselaar H, et al. Human Dectin 1 deficiency and mucocutaneous fungal infections. N Engl J Med 2009;361:1760-7.
24. Puel A, Cyppowyj S, Bustamante J, Wright JF, Liu L, Kyung Lim H, et al. Chronic mucocutaneous candidiasis in humans with inborn errors of interleukin-17 immunity. Science 2011;332:65-8.
25. Eyerich K, Foerster S, Rombold S, Seidl HP, Behrendt H, Hofmann H, et al. Patients with chronic mucocutaneous candidiasis exhibit reduced production of Th-17 associated cytokines Il-17 and IL-22. J Invest Dermatol 2008;128: 2640-5.